SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001499
Filing Date
2021-08-16
Accepted
2021-08-16 16:42:30
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tern-20210630.htm   iXBRL 10-Q 2290324
2 EX-31.1 tern-20210630ex31_1.htm EX-31.1 15838
3 EX-31.2 tern-20210630ex31_2.htm EX-31.2 15839
4 EX-32.1 tern-20210630ex32_1.htm EX-32.1 9901
5 EX-32.2 tern-20210630ex32_2.htm EX-32.2 9908
  Complete submission text file 0000950170-21-001499.txt   8948604

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20210630_pre.xml EX-101.PRE 348647
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tern-20210630_cal.xml EX-101.CAL 49657
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20210630.xsd EX-101.SCH 55407
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tern-20210630_def.xml EX-101.DEF 201094
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20210630_lab.xml EX-101.LAB 463693
11 EXTRACTED XBRL INSTANCE DOCUMENT tern-20210630_htm.xml XML 1817383
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39926 | Film No.: 211179159
SIC: 2834 Pharmaceutical Preparations